The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Pimblett, Emily
    Chief Accounting Officer born in April 1983
    Individual (1 offspring)
    Officer
    2024-08-08 ~ now
    OF - director → CIF 0
  • 2
    Brennan, Aoife
    Ceo born in June 1975
    Individual (1 offspring)
    Officer
    2024-08-08 ~ now
    OF - director → CIF 0
  • 3
    Corporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, United States
    Corporate (1 offspring)
    Person with significant control
    2021-08-21 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 4
    3rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom
    Corporate (7 parents, 2461 offsprings)
    Total Assets Less Current Liabilities (Company account)
    1 GBP2016-09-30
    Officer
    2019-12-05 ~ now
    OF - secretary → CIF 0
Ceased 5
  • 1
    Levin, Andrew David
    Investor born in November 1976
    Individual (1 offspring)
    Officer
    2019-03-20 ~ 2019-12-18
    OF - director → CIF 0
    Andrew David Levin
    Born in November 1976
    Individual (1 offspring)
    Person with significant control
    2019-03-20 ~ 2019-12-18
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Palmer-phillips, Joanne Eryl, Dr
    Chief Development Officer born in June 1973
    Individual (2 offsprings)
    Officer
    2021-10-08 ~ 2024-08-13
    OF - director → CIF 0
  • 3
    Gaby, Helen Louise
    Senior Director Operations Uk born in March 1968
    Individual
    Officer
    2021-10-08 ~ 2024-08-15
    OF - director → CIF 0
  • 4
    Morisset, Valerie Daniele
    Executive Vp R&D And Chief Scientific Officer born in October 1969
    Individual
    Officer
    2019-12-18 ~ 2024-08-23
    OF - director → CIF 0
    Mrs Valerie Daniele Morisset
    Born in October 1969
    Individual
    Person with significant control
    2019-12-18 ~ 2021-10-01
    PE - Right to appoint or remove directors → CIF 0
  • 5
    BROWN RUDNICK BERLACK ISRAELS LLP - 2008-04-29
    BROWN RUDNICK FREED & GESMER LLP - 2002-02-12
    8, Clifford Street, London, United Kingdom
    Corporate (26 parents, 1 offspring)
    Profit/Loss (Company account)
    4,324,082 GBP2023-01-01 ~ 2023-12-31
    Officer
    2019-03-20 ~ 2019-05-15
    PE - secretary → CIF 0
parent relation
Company in focus

ELIEM THERAPEUTICS (UK) LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
212023-01-01 ~ 2023-12-31
242022-01-01 ~ 2022-12-31
Intangible Assets
7,373,319 GBP2023-12-31
7,841,467 GBP2022-12-31
Debtors
Current
2,195,893 GBP2023-12-31
9,413,891 GBP2022-12-31
Cash at bank and in hand
3,508,583 GBP2023-12-31
12,303,385 GBP2022-12-31
Current Assets
5,704,476 GBP2023-12-31
21,717,276 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-1,920,827 GBP2023-12-31
-3,778,873 GBP2022-12-31
Net Current Assets/Liabilities
3,783,649 GBP2023-12-31
17,938,403 GBP2022-12-31
Total Assets Less Current Liabilities
11,156,968 GBP2023-12-31
25,779,870 GBP2022-12-31
Net Assets/Liabilities
11,156,968 GBP2023-12-31
25,779,870 GBP2022-12-31
Equity
Called up share capital
788 GBP2023-12-31
661 GBP2022-12-31
404 GBP2022-01-01
Share premium
110,299,293 GBP2023-12-31
107,064,005 GBP2022-12-31
60,725,911 GBP2022-01-01
Other miscellaneous reserve
2,167,152 GBP2023-12-31
2,854,392 GBP2022-12-31
1,519,692 GBP2022-01-01
Retained earnings (accumulated losses)
-101,310,265 GBP2023-12-31
-84,139,188 GBP2022-12-31
-36,725,834 GBP2022-01-01
Equity
11,156,968 GBP2023-12-31
25,779,870 GBP2022-12-31
25,520,173 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-17,171,077 GBP2023-01-01 ~ 2023-12-31
-47,413,354 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-17,171,077 GBP2023-01-01 ~ 2023-12-31
-47,413,354 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-17,171,077 GBP2023-01-01 ~ 2023-12-31
-47,413,354 GBP2022-01-01 ~ 2022-12-31
Comprehensive Income/Expense
-17,171,077 GBP2023-01-01 ~ 2023-12-31
-47,413,354 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
127 GBP2023-01-01 ~ 2023-12-31
257 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
3,235,415 GBP2023-01-01 ~ 2023-12-31
46,338,351 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
127 GBP2023-01-01 ~ 2023-12-31
257 GBP2022-01-01 ~ 2022-12-31
Equity - Income/Expense Recognised Directly
2,548,175 GBP2023-01-01 ~ 2023-12-31
47,673,051 GBP2022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
16,287,474 GBP2023-12-31
16,287,474 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
8,914,155 GBP2023-12-31
8,446,007 GBP2022-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
7,373,319 GBP2023-12-31
7,841,467 GBP2022-12-31
Other Debtors
Current
241,227 GBP2022-12-31
Prepayments/Accrued Income
Current
202,895 GBP2023-12-31
2,653,090 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
1,992,998 GBP2023-12-31
6,519,574 GBP2022-12-31
Trade Creditors/Trade Payables
Current
37,029 GBP2023-12-31
728,648 GBP2022-12-31
Amounts owed to group undertakings
Current
12,012 GBP2023-12-31
9,837 GBP2022-12-31
Taxation/Social Security Payable
Current
414,687 GBP2023-12-31
122,747 GBP2022-12-31
Other Creditors
Current
692,385 GBP2023-12-31
32,842 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
764,714 GBP2023-12-31
2,884,799 GBP2022-12-31
Creditors
Current
1,920,827 GBP2023-12-31
3,778,873 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
600 shares2023-12-31
500 shares2022-12-31
Par Value of Share
Class 1 ordinary share
1.002023-01-01 ~ 2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
171,125 GBP2023-12-31
148,123 GBP2022-12-31
  • ELIEM THERAPEUTICS (UK) LTD
    Info
    Registered number 11893311
    3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT
    Private Limited Company incorporated on 2019-03-20 (6 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.